The study began in 1994 and had up to 36 months of follow up for primary efficacy measurements and nonserious adverse events and up to 40 months of follow up for serious adverse events <a href=http://sviagrass.monster>tucker carlson viagra</a> As a breast cancer medication, tamoxifen blocks the effects of estrogen which discourages the further growth of tumors